Daniel Aberdam completed his first degrees at the Pierre and Marie Curie University (Paris, France) and his Ph.D. degree at the Weizmann Institute (Israel) on the oncogenic potential of homeotic genes under the supervision of Professor Leo Sachs. He currently holds the position of INSERM Director of Research, Director of the INSERM U898 (Nice University, France) and the INSERTECH laboratory (Technion, Israel). His scientific interests focus on epidermal gene regulation and skin physiopathology. Recently, his group developed strategies to recapitulate in vitro embryonic skin development derived from embryonic stem cell lines and from patient reprogrammed cells. The current projects developed by his teams are centered around the use of pluripotent stem cells as cellular models for skin, cornea, and cardiac pathophysiology.
Biography Updated on 1 December 2011